1、 JIA X, ZHANG J, ZHUANG B, et al. Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the Aco Art I Trial [J]. JACC Cardiovasc Interv, 2016, 9(18): 1941-1949. JIA X, ZHANG J, ZHUANG B, et al. Acotec drug-coated balloon catheter: randomized, multicenter, controlled clinical study in femoropopliteal arteries: evidence from the Aco Art I Trial [J]. JACC Cardiovasc Interv, 2016, 9(18): 1941-1949.
2、 孙灿龙,杜建时,韩冬梅.药物涂层球囊对老年患者下肢动脉硬化闭塞症支架内狭窄的疗效 [J]. 中国老年学杂志,2017,37(11): 5375-5377. 孙灿龙,杜建时,韩冬梅.药物涂层球囊对老年患者下肢动脉硬化闭塞症支架内狭窄的疗效 [J]. 中国老年学杂志,2017,37(11): 5375-5377.
3、 ROBERTS D, NIAZI K, MILLER W, et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the definitive Ca trial [J]. Catheter Cardiovasc Interv, 2014, 84(2): 236-244. ROBERTS D, NIAZI K, MILLER W, et al. Effective endovascular treatment of calcified femoropopliteal disease with directional atherectomy and distal embolic protection: final results of the definitive Ca trial [J]. Catheter Cardiovasc Interv, 2014, 84(2): 236-244.
4、 MC KINSEY J F, ZELLER T, ROCHA-SINGH K J, et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the definitive le study [J]. JACC Cardiovasc Interv, 2014, 7(8): 923-933. MC KINSEY J F, ZELLER T, ROCHA-SINGH K J, et al. Lower extremity revascularization using directional atherectomy: 12-month prospective results of the definitive le study [J]. JACC Cardiovasc Interv, 2014, 7(8): 923-933.
5、 POWELL R J. Endovascular treatment in the superficial femoral artery: which devices, where? [J]. Semin Vasc Surg, 2008,21(4): 180-185. POWELL R J. Endovascular treatment in the superficial femoral artery: which devices, where? [J]. Semin Vasc Surg, 2008,21(4): 180-185.
6、 SIMPSON J B. How atherectomy began: a personal history [J]. Am J Cardiol, 1993,72(13): 3E-5E. SIMPSON J B. How atherectomy began: a personal history [J]. Am J Cardiol, 1993,72(13): 3E-5E.
7、 SOGA Y, TOMOI Y, SATO K, et al. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease [J]. Cardiovasc Interv Ther, 2013, 28(3): 250-257. SOGA Y, TOMOI Y, SATO K, et al. Clinical outcome after endovascular treatment for isolated common femoral and popliteal artery disease [J]. Cardiovasc Interv Ther, 2013, 28(3): 250-257.
8、 ROCHA-SINGH K J, JAFF M R, CRABTREE T R, et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease [J]. Catheter Cardiovasc Interv, 2007, 69(6): 910-919. ROCHA-SINGH K J, JAFF M R, CRABTREE T R, et al. Performance goals and endpoint assessments for clinical trials of femoropopliteal bare nitinol stents in patients with symptomatic peripheral arterial disease [J]. Catheter Cardiovasc Interv, 2007, 69(6): 910-919.
9、 师贞爱,刘育齐,何子聪,等. Turbohawk斑块旋切及Rotarex除栓导管治疗下肢动脉硬化闭塞症的现状 [J]. 中国血管外科杂志,2017,9(4): 306-310. 师贞爱,刘育齐,何子聪,等. Turbohawk斑块旋切及Rotarex除栓导管治疗下肢动脉硬化闭塞症的现状 [J]. 中国血管外科杂志,2017,9(4): 306-310.